The peptide MEKVQYLTRSAIRRASTIEMPQQAR-Cys corresponding to residues 1-25 of phospholamban was found to inhibit the ATPase activity of skeletal muscle Ca2+-ATPase, but to have no effect on the Ca2+-dependence of its activity. The peptide was found to decrease the rate of the Ca2+ transport step (ElPCa2-. E2P) by a factor of 2.4. The rate of this same step was decreased by poly(L-Arg) by a factor of 2.2. The peptide shifted
INTRODUCTION
Phospholamban is a small protein of 52 amino acids which inhibits the Ca2+-ATPase of cardiac sarcoplasmic reticulum (Tada, 1992) . Although skeletal muscle sarcoplasmic reticulum contains no phospholamban, the skeletal muscle Ca2+-ATPase is inhibited by phospholamban when they are co-reconstituted (Szymanska et al., 1990; Tada, 1992; Vorherr et al., 1992) . Phospholamban contains a hydrophilic N-terminal domain (Met-1 to and a hydrophobic C-terminal domain (Leu-31 to which is likely to be a transmembrane a-helix. The hydrophilic domain contains two regions, an N-terminal region from Met-I to Pro-21 predicted to be a-helical and a less structured region linking the N-terminal region to the transmembrane a-helix (Tada, 1992) . Binding of the hydrophilic domain of phospholamban to cardiac Ca2+-ATPase has been shown to reduce the maximum rate of hydrolysis of ATP with no effect on the affinity of the ATPase for Ca2 , whereas binding of the hydrophobic domain decreases the affinity of the ATPase for Ca2+ with no effect on the maximum rate of hydrolysis (Sasaki et al., 1992) .
The kinetics of the ATPase are usually discussed in terms of the El-E2 model shown in Scheme 1. It is proposed that in the El -
ElCa2
ElCa2 shifts the E2-El equilibrium towards El but has no effect on phosphorylation of the ATPase by Pi.
MATERIALS AND METHODS
Sarcoplasmic reticulum from rabbit skeletal muscle and purified Ca2+-ATPase were prepared as described in East and Lee (1982) . ATPase activities were measured using a coupled enzyme assay as described (East and Lee, 1982) . Ca2+ concentrations were calculated using the binding constants for EGTA, Ca2+, Mg2+ and H+ given by Godt (1974) . Poly(L-Arg) (molecular-mass range 5000-15000 Da) was obtained from Sigma.
The peptides MEKVQYLTRSAIRRASTIEMPQQAR-Cys [PLN(I-25)] and RRASTIEMPQQAR-Cys [PLN(13-25)] corresponding to residues 1 to 25 and 13 to 25 respectively of rabbit heart phospholamban were synthesized with a C-terminal cysteine by the method of Merrifield (1986) and checked for purity by h.p.l.c. on a reversed-phase C8 column. . The ATPase (0.2 mg/ml) incubated in buffer (pH 7.2, 40 mM Hepes/Tris, 5 mM Mg2+, 100 mM KCl, 100 ,M Ca2+) was mixed in a 1:1 ratio with the same buffer containing 50 ,tM [y-32P]ATP to give a final concentration of ATP of 25 ,uM, followed by quenching with 12 % (v/v) trichloroacetic acid/0.2 M phosphoric acid.
The ATPase was labelled with nitrobenzo-2,1,3-oxadiazole (NBD) as described previously (Wictome et al., 1992) . Measurements of NBD fluorescence were performed at 25°C using an SLM Amino 8000C fluorimeter with excitation and emission wavelengths of 430 and 520 nm respectively.
Structures were modelled using QUANTA.
RESULTS
The peptide PLN(1-25) which corresponds to the first 25 residues of phospholamban, when added to uncoupled sarcoplasmic reticulum vesicles prepared from skeletal muscle, inhibits ATPase activity ( Figure 1 ). As shown in Figure 1 , the peptide had no significant effect on the Ca2+-dependence of activity, either at the sites of high affinity resulting in stimulation of activity or at the sites of low affinity resulting in inhibition of activity. Poly(L-Arg) also inhibited ATPase activity, with a maximal inhibition of 41 % and an IC50 of 0.2 jtM, based on an average molecular mass of 10000 (results not shown). The peptide PLN(13-25) had no detectable effect on ATPase activity (results not shown). Orlowski and Champeil (1991) have shown that the rate of Ca2' dissociation from the phosphorylated ATPase can be measured by pre-equilibrating the ATPase in leaky vesicles with 45Ca2' and then perfusing them on Millipore filters with 40Ca2+ and ATP. The experiment relies on the rate of phosphorylation of the ATPase being much faster than the rate of dissociation of 45Ca2+ from the unphosphorylated ATPase so that the observed rate of loss of 45Ca2+ gives the rate of the E1PCa2 --E2P step in Scheme 1 (Orlowski and Champeil, 1991) . In the absence of peptide, the dissociation of Ca2+ fits to a single-exponential process with a rate constant of 29.8 + 4.0 s-1. In the presence of 25 ,uM PLN(1-25) the rate of dissociation of Ca2+ is reduced and fits to a rate constant of 12.1 + 3.0 s-' (Figure 2a ). In the presence (0) (Figure 2b ).
Effects of PLN(I-25) on the E2-El equilibrium of the ATPase were studied by making use of the conformational sensitivity of the ATPase labelled with NBD (Wakabayashi et al., 1990; Wictome et al., 1992) . As shown in Figure 3 , the fluorescence emission intensity of NBD-labelled ATPase increases with increasing pH. It has been shown that this effect of pH is consistent with Scheme 2 for the E2-E1 equilibrium, with values for K.6, KH7 and K1 of 5 x 105 M-1, 3.0 x 108 M-1, and 4.0 respectively (Henderson et al., 1994) , and for the sample used to obtain the data shown in Figure 3, Figure 3 , the data fit to the same model but with a value for the equilibrium constant El/E2 of 16.0. The concentration-dependence of the effect of PLN(1-25) at pH 7.0 fits to a Kd value of 7.4,tM ( Figure 4) ; the data show that the effect of PLN(1-25) is almost saturated at 35 ,tM, which is the concentration used to obtain the data in Figure 3 .
PLN(1-25) had no significant effect on the rate of phosphorylation of the ATPase when the ATPase incubated in the presence of Ca2l was mixed with ATP; rates of phosphorylation were 87 + 21 and 71 + 18 s-1 respectively in the absence and presence of 25 j#M PLN(1-25) ( Figure 5 ). PLN(1-25) also had no significant effect on the level of phosphorylation of the ATPase by Pi observed at pH 6.3 in the absence of Ca2+, at a Mg2c oncentration of 5 mM (Table 1) .
DISCUSSION
The activity of the SERCA2 isoform of the Ca2+-ATPase expressed in smooth muscle, slow skeletal muscle and cardiac muscle is modulated by interaction with phospholamban (Eggermont et al., 1990). Phospholamban is a homopentameric protein which in the unphosphorylated form interacts with the Ca2+-ATPase, reducing the maximal rate of the ATPase and reducing the affinity of the ATPase for Ca2+ (Morris et al., 1991; Sasaki et al., 1992) . Phosphorylation of phospholamban by cyclic AMP-, cyclic-GMP-, or Ca2+/calmodulin-dependent protein kinases prevents interaction with the Ca2+-ATPase (Eggermont et al., 1990) . The activity of the SERCAI isoform of the Ca2+-ATPase found in the sarcoplasmic reticulum of fast skeletal muscle is modulated by interaction with phospholamban if both the ATPase and phospholamban are co-expressed in COS cells (Toyofuku et al., 1993) , even though phospholamban is not found in the sarcoplasmic reticulum of fast skeletal muscle. The activity of the SERCA3 isoform of the Ca2+-ATPase is, however, not modulated by interaction with phospholamban when coexpressed in COS cells with phospholamban (Toyofuku et al., 1993) .
As shown in Figure 1 , the peptide PLN(I-25), corresponding to the hydrophilic domain of phospholamban, inhibits ATP hydrolysis by the Ca2+-ATPase of skeletal muscle; a maximum inhibition of 44 % was observed with half maximal inhibition at 5,IM PLN(1-25). Sasaki et al. (1992) (Stefanova et al., 1991) and the oxalate transporter is unlikely to be affected by phospholamban. Although the molar ratio of peptide: ATPase required for inhibition is relatively high (half maximal inhibition at a molar ratio of 136: 1 in Figure 1 ) this presumably reflects the relatively high water solubility of the polar peptide. As reported by Sasaki et al. (1992) for the cardiac Ca2+-ATPase, PLN(1-25) had no significant effect on the Ca2+-dependence of ATPase activity (Figure 1) , only on maximal rate. We made a similar observation for spermine and other polycationic compounds . Inhibition by spermine was found to follow from a decrease in the rate of the EIPCa2-+ E2P transition, with no effect on the rate of phosph.orylation or dephosphorylation . As shown in Figure 2(a), 25,M PLN(1-25) reduces the rate of the E1PCa2 -* E2P transition by a factor of 2.4. Poly(L-Arg), which decreases ATPase activity by up to 41 %, causes a decrease in the rate of this transition by a factor of 2.2 at a concentration of 10 M (Figure 2b) .
PLN(1-25) also shifts the E2-E1 equilibrium for the ATPase towards El, the data being consistent with a 4-fold increase in the equilibrium constant E1/E2 (Figure 3) . In terms of Scheme 3, this implies 4-fold stronger binding of to the El conformation than to the E2 conformation, with binding to El or E2 being independent of pH. From Scheme 3, the effective dissociation constant Ke" for PLN(1-25) to the ATPase is given by:
where KE2 and KEl are dissociation constants for PLN(1-25) for E2 and El respectively. With KE2 = 4.0 x KEl and Kefl = 7.4,M (Figure 4 ), KE2 and KEl become 10 and 3 1aM respectively. The value of Keff is comparable with the concentration of PLN(1-25) causing half-maximal inhibition of ATPase activity (5 ,IM at pH 7.2) making it likely that both effects follow from binding at one site. Spermine was also found to bind more strongly to the El than to the E2 conformation of the ATPase .
Although shifted the E2-E1 equilibrium towards El (Figure 3 ) it had no significant effect on the Ca2+-dependence of ATPase activity (Figure 1) . A corresponding observation was made in studies of the effects of nonylphenol on the activity of the ATPase where nonylphenol shifted the E2-E1 equilibrium towards E2, but again with no effect on the Ca2+-dependence of activity (Michelangeli et al., 1990) . Simulations show that the dependence of ATPase activity on the concentration of Ca 2+ is only slightly affected by the value of the equilibrium constant El/E2 as strong binding of MgATP to El strongly favours ElMgATP over E2 (Michelangeli et al., 1990) .
Spermine was found to decrease phosphorylation of the ATPase by Pi in the absence of Ca2+, by competition with Mg2+ . As shown in Table 1 , PLN(1-25) had no significant effect on the measured level of phosphorylation by Pi at concentrations inhibiting ATPase activity. This would suggest that the effects of spermine were less specific than those of , and that the effects of spermine on phosphorylation by Pi followed from binding at a site other than that affecting the E2-El and EIPCa2-* E2P steps.
PLN(I-25) had no effect on the rate of phosphorylation of the ATPase by ATP ( Figure 5) ; spermine was also observed to have no effect on the rate of this step . We conclude that the effects of Figure 6 The structures of spermine and of the hydrophilic region of phospholamban Shown is a comparison of the structures of spermine (left) and residues 2-23 of phospholamban (right) . Spermine is shown in a fully extended conformation, with distances between nitrogen atoms given in A (1 A = 0.1 nm). For phospholamban just the a-carbon backbone and residues Arg-9, Arg-13, and Arg-14 are shown for clarity. Residues 2-23 of phospholamban have been modelled as a slightly distorted a-helix, in an energy-minimized conformation with separations between nitrogens of residues Arg-9 and Arg-13, and Arg-14 (as shown by the broken lines) of 6.8 and 5.2 A respectively. equilibrium constant for just one step in the reaction sequence because the product of the equilibrium constants around the ATPase cycle must (for leaky vesicles) be a constant, equal to the equilibrium constant for the hydrolysis of ATP. An increase in the equilibrium constant E1/E2 requires a decrease in the equilibrium constant E2P/EIPCa2, if these are the only two steps modified by binding of . A decrease in the equilibrium constant E2P/EIPCa2 would be consistent with the observed decrease in the rate of the ElPCa2-+ E2P step.
We conclude that the hydrophilic domain of phospholamban can bind to the Ca2+-ATPase of cardiac or skeletal muscle and inhibit ATPase activity by decreasing the rate of the Ca2+-transport step. The inhibition of this same step by spermine or poly(L-Arg) (Figure 2 ) implies that cationic sites on phospholamban are involved in the interaction. Since the peptide PLN(13-25) had no detectable effect on ATPase activity (results not shown), cationic residues in the region 1-12 are presumably important; this is in agreement with the results of Sasaki et al. (1992) who found no inhibition of ATPase activity with a peptide corresponding to residues 8-47 of phospholamban and with the results ofToyofuku et al. (1993) who showed that residues between Glu-2 and Ile-18 were important for interaction with the ATPase. Since spermine and spermidine inhibit ATPase activity with similar potencies, but N'-acetylspermidine causes no inhibition , it is likely that binding of spermine to the ATPase involves three of the four nitrogen centres (Figure 6 ). It has been suggested that the hydrophilic domain of phospholamban between residues 2 and 23 can adopt an a-helical conformation (Tada, 1992) . Figure  6 shows an energy-minimized structure for this region of phospholamban modelled as a slightly distorted a-helix with a separation between the nitrogens of Arg-9, Arg-13 and Arg-14 equal to that between the terminal and central nitrogens of spermine.
Two regions on the Ca2+-ATPase have been identified as being important for interaction with phospholamban (James et al., 1989; Toyofuku et al., 1993) . The first is a region between Asp-370 and Lys-400, close to the residue on the ATPase (Asp-351) phosphorylated by ATPase. This region of the ATPase has been shown, by using anti-peptide antibodies, to be surface exposed (Mata et al., 1992) , consistent with its proposed interaction with phospholamban (James et al., 1989; Toyofuku et al., 1993) . Toyofuku et al. (1993) have shown that the nucleotidebinding/hinge region between Arg-467 and Arg-743 is also involved in the interaction with phospholamban. Anti-peptide antibody-binding studies have shown considerable surface exposure in this region of the ATPase (Mata et al., 1992) . Tada (1992) has suggested that the hydrophilic domain of phospholamban consists of an a-helical structure between Met-I and Pro-21 and a less ordered structure between Gln-22 and Asn-30. If the region between Gln-22 and Asn-30 is fully extended, it would have an end-to-end length of 30 A. The separation between Pro-21 and Arg-9 in the structure shown in Figure 6 is 17 A. Thus the maximum height above the membrane surface of the binding-site region proposed in Figure 6 would be approx. 47 A. We have estimated heights of Cys-344, Glu-439 and Cys-670/Cys-674 above the membrane surface to be 45, 70, and 54 A respectively Stefanova et al., 1993; Baker et al., 1994) . Thus the proposed structure for the binding-site region on phospholamban is compatible with the suggested sites of interaction on the ATPase.
